Somatostatin receptor scintigraphy in a patient with an epigastric mass and multiple liver metastases

S. Fanti, B. Bellanova, A. Chiti, A. Romeo, A. Petronelli, A. Panetta, A. Martoni, F. Bertoni, E. Bombardieri, N. Monetti

Research output: Contribution to journalArticlepeer-review

Abstract

A patient with an epigastric mass and multiple liver metastases with a histopathologic diagnosis of adenocarcinoma was treated with combined chemohormonal therapy. She had a poor response, despite intense and repeated treatment. Somatostatin receptor scintigraphy with In-111 pentetreotide demonstrated the presence of somatostatin receptors in the primary lesion and in the liver metastasis, suggesting the tumor was of neuroendocrine nature. This finding led to a sudden change in treatment as a result of the beneficial use of octreotide, and to a revision in the diagnosis with pathologic recognition of a carcinoid. This case underlines the clinical impact of somatostatin receptor scintigraphy in patient management by providing information on the somatostatin receptor status of the tumor.

Original languageEnglish
Pages (from-to)802-803
Number of pages2
JournalClinical Nuclear Medicine
Volume22
Issue number11
DOIs
Publication statusPublished - 1997

Keywords

  • Carcinoid Diagnosis
  • Diagnostic Use
  • In-111 Pentetreotide
  • Somatostatin Receptor Scintigraphy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Fingerprint

Dive into the research topics of 'Somatostatin receptor scintigraphy in a patient with an epigastric mass and multiple liver metastases'. Together they form a unique fingerprint.

Cite this